DRUG FIRM MOVES TO BLOCK RX IMPORTS

MARLTON, N.J. -- Cheap prescriptions from Canada are becoming a big business, with estimates placing its value as high as $650 million, but last month GlaxoSmithKline here launched an initiative to staunch the flow.The drug maker implemented a plan to halt the supply of prescription drugs to Canadian pharmacies that export to the United States. This latest development is another attempt to stop the

MARLTON, N.J. -- Cheap prescriptions from Canada are becoming a big business, with estimates placing its value as high as $650 million, but last month GlaxoSmithKline here launched an initiative to staunch the flow.

The drug maker implemented a plan to halt the supply of prescription drugs to Canadian pharmacies that export to the United States. This latest development is another attempt to stop the revenue bleeding at U.S. retail pharmacies like supermarkets.

U.S. pharmacies,

Register to view the full article